Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

Background: Urinary incontinence (UI), particularly urge urinary incontinence (UUI), is a prevalent condition that worsens ... The odds ratio (OR) and 95% confidence interval (95% CI) of the ...

Abdominal pain in your upper or lower pelvis where your bladder sits could have a non-infectious cause. Learn what causes ...

Photo: Dr. Jennifer Kuo. Courtesy of Trinity Health Community News Dr. Jennifer Kuo, a urologist with Trinity Health IHA ...

Additionally, the average daily number of urge urinary incontinence episodes was ... of Gemtesa is an important milestone for the men with unresolved symptoms of OAB while being treated for ...

As with any new supplement, it's crucial to consult a healthcare provider before starting ProstaVive, particularly if you have pre-existing conditions, are on other medications, or are undergoing ...

Many people believe that urinary tract infections (UTIs) and incontinence are more common in women, but they can also affect ...

Pelvic floor dysfunction — or PFD — is a term for a variety of disorders that affect the muscles in your pelvic floor. If the connective tissue or muscles in your pelvis weaken over time or get ...